BackLifeMD- 8.875% PRF PERPETUAL USD 25 - Ser A Overview

LifeMD- 8.875% PRF PERPETUAL USD 25 - Ser A Current Cash

LifeMD- 8.875% PRF PERPETUAL USD 25 - Ser A's current cash is $25M.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$25.14M
↓ 30.60% YoYΔ $-11.09M vs prior year quarter

Peer trimmed avg / median

Loading

LifeMD- 8.875% PRF PERPETUAL USD 25 - Ser A Current Cash History

Loading

LifeMD- 8.875% PRF PERPETUAL USD 25 - Ser A vs. peers: Current Cash Comparison

Loading

LifeMD- 8.875% PRF PERPETUAL USD 25 - Ser A Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

LifeMD- 8.875% PRF PERPETUAL USD 25 - Ser A (LFMDP) FAQ

As of the most recent data (June 2026), LFMDP shows a current cash of $25M. That compares with $36M in the prior-year period — down 30.6% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, LFMDP's current cash is now $25M (was $36M) — a 30.6% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether LifeMD- 8.875% PRF PERPETUAL USD 25 - Ser A is outperforming or lagging.

Tracking LFMDP's current cash over time shows whether LifeMD- 8.875% PRF PERPETUAL USD 25 - Ser A is scaling, shrinking, or reshaping that part of the business. The current reading is $25M That compares with $36M in the prior-year period — down 30.6% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this current cash page, Stockcircle has LifeMD- 8.875% PRF PERPETUAL USD 25 - Ser A's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect current cash (currently $25M) with ownership activity and broader fundamentals.

LifeMD- 8.875% PRF PERPETUAL USD 25 - Ser A's current cash is $25M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.